- Home
- BLBX vs HOOK Comparison
BLBX vs HOOK Comparison
Compare BLBX & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLBX
- HOOK
- Stock Information
- Founded
- BLBX 2014
- HOOK 2011
- Country
- BLBX United States
- HOOK United States
- Employees
- BLBX N/A
- HOOK N/A
- Industry
- BLBX EDP Services
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- BLBX Technology
- HOOK Health Care
- Exchange
- BLBX Nasdaq
- HOOK Nasdaq
- Market Cap
- BLBX 10.6M
- HOOK 9.3M
- IPO Year
- BLBX N/A
- HOOK 2019
- Fundamental
- Price
- BLBX $3.25
- HOOK $0.85
- Analyst Decision
- BLBX
- HOOK Buy
- Analyst Count
- BLBX 0
- HOOK 4
- Target Price
- BLBX N/A
- HOOK $10.67
- AVG Volume (30 Days)
- BLBX 47.9K
- HOOK 38.5K
- Earning Date
- BLBX 05-14-2025
- HOOK 05-08-2025
- Dividend Yield
- BLBX N/A
- HOOK N/A
- EPS Growth
- BLBX N/A
- HOOK N/A
- EPS
- BLBX N/A
- HOOK N/A
- Revenue
- BLBX $2,566,946.00
- HOOK $43,946,000.00
- Revenue This Year
- BLBX N/A
- HOOK N/A
- Revenue Next Year
- BLBX N/A
- HOOK N/A
- P/E Ratio
- BLBX N/A
- HOOK N/A
- Revenue Growth
- BLBX N/A
- HOOK 118.32
- 52 Week Low
- BLBX $1.51
- HOOK $0.72
- 52 Week High
- BLBX $6.00
- HOOK $10.50
- Technical
- Relative Strength Index (RSI)
- BLBX 51.47
- HOOK 39.54
- Support Level
- BLBX $2.82
- HOOK $0.73
- Resistance Level
- BLBX $3.44
- HOOK $0.85
- Average True Range (ATR)
- BLBX 0.25
- HOOK 0.08
- MACD
- BLBX 0.02
- HOOK 0.03
- Stochastic Oscillator
- BLBX 82.14
- HOOK 77.25
About BLBX Blackboxstocks Inc.
Blackboxstocks Inc is a financial technology and social media hybrid platform offering real-time proprietary analytics and news for stock and options traders of all levels. Its web-based software (the Blackbox System) employs predictive technology enhanced by artificial intelligence to find volatility and unusual market activity that may result in a rapid change in the price of a stock or option. It provides users with a fully interactive social media platform that is integrated into its dashboard, enabling users to exchange information and ideas quickly and efficiently through a common network. The company introduced a live audio/video feature that allows members to broadcast on their channels to share trading strategies and market insight within the Blackbox community.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.